AstraZeneca Asthma Drug Shows Positive Results – Wall Street Journal


Reuters

AstraZeneca Asthma Drug Shows Positive Results
Wall Street Journal
Bing Yao, head of respiratory medicine at the company's MedImmune unit, said benralizumab acted directly on the cells that are thought to cause attacks in severe asthma patients. He said the Glaxo and Teva drugs, by contrast, act indirectly by
AstraZeneca asthma drug hits goal, to enter competitive marketReuters
AstraZeneca climbs after positive asthma treatment resultsThe Guardian
AstraZeneca: Asthma drug trial results positiveMarketWatch
FierceBiotech –Nasdaq
all 13 news articles »

View full post on asthma – Google News

AstraZeneca asthma drug hits goal, to enter competitive market – Reuters


Reuters

AstraZeneca asthma drug hits goal, to enter competitive market
Reuters
L) drive to rebuild its portfolio of new medicines received a boost with positive results for an experimental biotech drug for severe asthma that the company previously flagged as a potential $2 billion-a-year seller. Benralizumab, which is likely to
AstraZeneca: Asthma drug trial results positiveMarketWatch
Astrazeneca Reports Results On Benralizumab Phase III Programme In Severe AsthmaNasdaq
TOP NEWS: AstraZeneca Gets Positive Benralizumab Phase III Trial ResultsLondon South East (registration) (blog)

all 6 news articles »

View full post on asthma – Google News

AstraZeneca boosted by good results for biotech asthma drug – Reuters


Reuters

AstraZeneca boosted by good results for biotech asthma drug
Reuters
LONDON AstraZeneca's (AZN.L) drive to rebuild its portfolio of new medicines received a boost on Tuesday with positive results for a biotech drug for severe asthma that the company has previously flagged as a potential $2 billion-a-year product.
AstraZeneca: Asthma drug trial results positiveMarketWatch
Astrazeneca Reports Results On Benralizumab Phase III Programme In Severe AsthmaNasdaq
TOP NEWS: AstraZeneca Gets Positive Benralizumab Phase III Trial ResultsLondon South East (registration) (blog)

all 4 news articles »

View full post on asthma – Google News

AstraZeneca: Asthma drug trial results positive – MarketWatch


Reuters UK

AstraZeneca: Asthma drug trial results positive
MarketWatch
LONDON–AstraZeneca PLC (AZN.LN) said Tuesday its potential new medicine benralizumab showed positive results in a Phase III trial for asthma treatment. The treatment "was well tolerated and achieved the primary endpoint in two pivotal Phase III …
AstraZeneca boosted by good results for biotech asthma drugReuters UK
Astrazeneca Reports Results On Benralizumab Phase III Programme In Severe AsthmaNasdaq
TOP NEWS: AstraZeneca Gets Positive Benralizumab Phase III Trial ResultsLondon South East (registration) (blog)

all 4 news articles »

View full post on asthma – Google News

Sweden says AstraZeneca used questionable asthma drug API from Indian plant – FiercePharma Manufacturing

Sweden says AstraZeneca used questionable asthma drug API from Indian plant
FiercePharma Manufacturing
AstraZeneca ($AZN) said last week it was closing a plant in India that made the API for asthma drugs, noting there is not much demand any longer for the terbutaline sulfate it makes. But what the U.K. company did not say was that before its closing

View full post on asthma – Google News

Global Preventive Asthma Drugs Market 2015-2019 with AstraZeneca, F. Hoffmann … – PR Newswire (press release)

Global Preventive Asthma Drugs Market 2015-2019 with AstraZeneca, F. Hoffmann
PR Newswire (press release)
The report, Global Preventive Asthma Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape of the global preventive asthma drugs market and its growth …

and more »

View full post on asthma – Google News

AstraZeneca embracing smart inhalers for asthma tracking & medication adherence – iMedicalApps


iMedicalApps

AstraZeneca embracing smart inhalers for asthma tracking & medication adherence
iMedicalApps
Adherium is an Australian company that makes a line of FDA cleared smart inhaler attachments that attach to a range of inhalers for asthma and chronic obstructive pulmonary disease (COPD). These devices, which include a touchscreen display for …

View full post on asthma – Google News

AstraZeneca Signs Partnership With Kyowa Hakko Kirin To Commercialize Asthma … – Lung Disease News


Lung Disease News

AstraZeneca Signs Partnership With Kyowa Hakko Kirin To Commercialize Asthma
Lung Disease News
It will also retain responsibility for furthering the drug's research and development in Japan, and keep hold of rights to participate in some of AstraZeneca's commercial activities. AstraZeneca will be accountable for all sales and marketing in asthma

View full post on asthma – Google News

AstraZeneca Signs Partnership With Kyowa Hakko Kirin To Commercialize … – Lung Disease News


Lung Disease News

AstraZeneca Signs Partnership With Kyowa Hakko Kirin To Commercialize
Lung Disease News
It will also retain responsibility for furthering the drug's research and development in Japan, and keep hold of rights to participate in some of AstraZeneca's commercial activities. AstraZeneca will be accountable for all sales and marketing in asthma

View full post on asthma – Google News